PD
Point72 (DIFC) Portfolio holdings
AUM
$1.25B
1-Year Return
9.31%
This Quarter Return
-0.11%
1 Year Return
+9.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.13B
AUM Growth
-$166M
(-13%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-13.54%
Top 10 Holdings %
Top 10 Hldgs %
21.99%
Holding
1,563
New
550
Increased
143
Reduced
166
Closed
561
Top Buys
| 1 |
Apple
AAPL
|
+$33.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$26.6M |
| 3 |
Spotify
SPOT
|
+$26.4M |
| 4 |
Amazon
AMZN
|
+$25.2M |
| 5 |
RTX Corp
RTX
|
+$24.8M |
Top Sells
| 1 |
Oracle
ORCL
|
+$35.4M |
| 2 |
Meta Platforms (Facebook)
META
|
+$24.6M |
| 3 |
Uber
UBER
|
+$23.9M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$23.6M |
| 5 |
Progressive
PGR
|
+$21.6M |
Sector Composition
| 1 | Technology | 19.64% |
| 2 | Industrials | 15.95% |
| 3 | Financials | 14.78% |
| 4 | Healthcare | 14.11% |
| 5 | Consumer Discretionary | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIGL
676
DELISTED
Vigil Neuroscience
VIGL
| $22K | ﹤0.01% |
+5,506
| New | +$22K |
|
677
Sandstorm Gold
SAND
$3.44B
| $22K | ﹤0.01% |
+4,043
| New | +$22K |
|
|
DHC
678
Diversified Healthcare Trust
DHC
$1.05B
| $21.7K | ﹤0.01% |
+7,110
| New | +$21.7K |
|
679
Biomea Fusion
BMEA
$118M
| $21.5K | ﹤0.01% |
+4,782
| New | +$21.5K |
|
|
MAGN
680
Magnera Corporation
MAGN
$404M
| $21.4K | ﹤0.01% |
+1,185
| New | +$21.4K |
|
681
First Community Corp
FCCO
$214M
| $21.3K | ﹤0.01% |
+1,233
| New | +$21.3K |
|
|
LGTY
682
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $21.2K | ﹤0.01% |
2,322
+1,819
| +362% | +$16.6K |
|
|
HTO
683
H2O America Common Stock
HTO
$1.75B
| $21K | ﹤0.01% |
+388
| New | +$21K |
|
684
Nelnet
NNI
$4.44B
| $20.9K | ﹤0.01% |
207
-143
| -41% | -$14.4K |
|
685
KORU Medical Systems
KRMD
$186M
| $20.8K | ﹤0.01% |
+7,864
| New | +$20.8K |
|
686
Acushnet Holdings
GOLF
$4.37B
| $20.8K | ﹤0.01% |
328
-7,042
| -96% | -$447K |
|
687
Aclaris Therapeutics
ACRS
$213M
| $20.2K | ﹤0.01% |
+18,319
| New | +$20.2K |
|
688
Acadia Pharmaceuticals
ACAD
$4.02B
| $20K | ﹤0.01% |
1,232
-76,131
| -98% | -$1.24M |
|
689
CoreCard
CCRD
$208M
| $19.9K | ﹤0.01% |
+1,365
| New | +$19.9K |
|
|
IVAC
690
DELISTED
Intevac Inc
IVAC
| $19.8K | ﹤0.01% |
+5,141
| New | +$19.8K |
|
691
Brown-Forman Class A
BF.A
$13.2B
| $19.8K | ﹤0.01% |
+448
| New | +$19.8K |
|
692
Duluth Holdings
DLTH
$133M
| $19.7K | ﹤0.01% |
+5,350
| New | +$19.7K |
|
693
BioXcel Therapeutics
BTAI
$54.3M
| $19.7K | ﹤0.01% |
+963
| New | +$19.7K |
|
694
AnaptysBio
ANAB
$637M
| $19.7K | ﹤0.01% |
+785
| New | +$19.7K |
|
695
Mesa Laboratories
MLAB
$327M
| $19.6K | ﹤0.01% |
+226
| New | +$19.6K |
|
696
Anterix
ATEX
$397M
| $19.3K | ﹤0.01% |
+488
| New | +$19.3K |
|
|
UHT
697
Universal Health Realty Income Trust
UHT
$569M
| $19.1K | ﹤0.01% |
487
-409
| -46% | -$16K |
|
698
Vontier
VNT
$6.34B
| $19K | ﹤0.01% |
+499
| New | +$19K |
|
699
Visteon
VC
$3.42B
| $19K | ﹤0.01% |
178
-2,693
| -94% | -$287K |
|
700
Noodles & Co
NDLS
$30.6M
| $18.8K | ﹤0.01% |
+11,912
| New | +$18.8K |
|